Upregulation of Hh signaling pathway activity by exposure to SHH lead to gefitinib tolerance accompanied by EMT induction and ABCG2 upregulation in EGFR-TKI-sensitive NSCLC cells. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.